Open-labelled, multicenter study of pazopanib eye drops in subjects with neovascular age-related macular degeneration.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Pazopanib (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 27 Nov 2015 New trial record